Brazil's central securities depository, CSD BR, has started live record mirroring of BTG Pactual investment fund shares on the public XRP Ledger, marking the first regulated use of blockchain for securities ownership in Brazil. While CSD BR remains the official record keeper, the XRP Ledger provides an independent audit layer accessible to authorized institutions under strict KYC and AML controls. This initiative aims to enhance transparency and verification without changing existing ownership or settlement processes. Future plans include expanding blockchain use to real estate and agribusiness debt securities and potentially enabling native blockchain issuance and trading among regulated participants.
Ripple's use of the XRP Ledger for Brazilian fund records is presented alongside Pluang's cryptocurrency market snapshot. As of Sep 30, 2026 11:21 WIB, 30 of 50 major cryptocurrencies on Pluang rose while 18 fell. Notable movers include SNX at Rp4.572 with a 5.49% increase and 99% buy order activity, GRT at Rp514 with a 5.61% decrease and 54% sell order activity, and AXS at Rp20.609 with a 4.47% rise and 71% sell order activity.
The iShares MSCI Italy ETF (EWI) provides focused exposure to Italian financials, utilities, and industrial sectors, benefiting from banking consolidation and EU-backed recovery projects. Despite Italy's low economic growth, the ETF trades above its ...
Argan faces potential project delays and cash flow risks due to data center moratoriums in Texas, but its strong balance sheet and ongoing AI and electrification investments provide long-term growth opportunities. The company is expected to deliver s...
Moonriver's MOVR token surged 51.73% in 24 hours, briefly reaching 1.489 USDT, coinciding with the migration period ending on September 30. Users had to submit migration applications by this deadline to maintain access to MOVR, which is transitioning...
Zcash (ZEC) has fallen below $1,500, shifting focus to the $1,400 level as a key support test after a sharp decline from $1,680. Significant selling activity has increased downward pressure, but whale investors are accumulating large amounts of ZEC, ...
AbbVie announced positive Phase 2 results for zumilokibart, a monoclonal antibody targeting IL-13, in adults with moderate-to-severe atopic dermatitis. All dose regimens met the primary endpoint with significant improvements in skin severity and itch...
